跳至主要内容
临床试验/NCT07309081
NCT07309081尚未招募不适用

Effect of Soleus Muscle Kinetic Control Training on Gait and Electromyographic Activity in Patients With Stroke

Cairo University0 个研究点目标入组 40 人开始时间: 2025年12月15日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
40
主要终点
muscle amplitude

研究概览

简要总结

this study was designed to investigate the effect of soleus muscle kinetic control training on Gait and electromyographic activity of the calf muscle in patients with stroke

详细描述

Stroke is a neurological condition characterized by a reduced blood supply to the brain tissue, resulting in paralysis of part or all of the body, limiting physical activity and social participation. Gait impairment accounts for the largest proportion of physical activity limitations in stroke patients and is characterized by muscle weakness, foot drop, spasticity, and foot deformity .Gait abnormalities following stroke are often disabling. Reduced ankle dorsiflexion, knee flexion, or hip flexion torques are often postulated causes of compromised toe clearing during the swing phase of gait. conversely, gait asymmetry and reduced walking speed has been attributed to weakness of the planter flexors.The kinetic control comprises balanced presentation of the movement choices with ideal interaction among the key components for the sensorimotor neuromuscular control that mediated by afferent sensory input, particularly the proprioceptive input, CNS integration, optimal motor co-ordination, and physiological stresses to assure functional dynamic stability and controlled mobility. forty patients with stroke will be assigned to two groups; one group will recieve kinetic control plus conventional therapy and control group will receive conventinoal therapy alone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

opaque sealed envelope

入排标准

年龄范围
45 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Ischemic or hemorrhagic stroke, as confirmed by CT and or MRI scan.
  • Age of the patients between 45 to 60 years old.
  • Ability to walk a minimum of 10 m with or without some physical assistance from a therapist (functional ambulation category more than 2).
  • Demonstrate weakness of the foot muscles, measured by muscle function tests according Medical Research council scale more than
  • Muscle tone of the affected lower limb ranges from 1 to +1 according to modified Ashworth scale.

排除标准

  • Unilateral neglect, hemianopia, or apraxia
  • Having any other neurological disorder affecting their lower extremities e.g. MS, Parkinsonism, peripheral neuropathy.
  • Patients with previous fractures in lower limb (Ankle or foot).
  • Patients with musculoskeletal disorder such as severe arthritis, ankle surgery, leg length discrepancy or contractures of fixed deformity of ankle joint.
  • Patients with visual, auditory impairment affecting their ability to complete tasks.
  • Patients with cognitive impairments

结局指标

主要结局

muscle amplitude

时间窗: up to eight weeks

A steady device will be used to assess muscle amplitude in the form of RMS with microvolt as the measurement unit

stance phase percentage

时间窗: up to eight weeks

the percentage of stance phase will be measured by steady device

giat function

时间窗: up to eight weeks

The Dynamic Gait Index (DGI) is an ordinal test of gait function evaluates the capacity to adapt gait to complex walking tasks encountered in everyday life. Eight aspects of gait are scored based on observation as the patient walks over a 6.1-m level surface. The rater records an ordinal score that ranges from 0 (unable or done very poorly) to 3 (normal score) for a total point value of 24. Scores of less than 21 appear to suggest risk for falls

step time

时间窗: up to eight weeks

the time of step by seconds will be measured by steady device

Gait Cycle time

时间窗: up to eight weeks

time of gait cycle (seconds) will be measured by steady device

single and double support percentage

时间窗: up to eight weeks

single and double support percentage of gait cycle will be measured by steady device

stride length

时间窗: up to eight weeks

stride length by cm will be measured by steady device

swing phase percentage

时间窗: up to eight weeks

the percentage of swing phase will be measured by steady device

cadence

时间窗: up to eight weeks

Cadence, number of steps per minute, will be measured by steady device

first and second double support percentage

时间窗: up to eight weeks

first and second double support percentage of gait cycle will be measured by steady devcie

gait speed

时间窗: up to eight weeks

gait speed by km/h will measured by steady device

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Habiba Mohamed Ahmed Mahmoud

principle investigator : habiba mohamed ahmed mahmoud

Cairo University

相似试验